Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


laura.winchester@psych.ox.ac.uk


ORCID ID https://orcid.org/0000-0003-3826-7694


she | her

Collaborators

Laura Winchester

DPhil

Associate Professor

  • Head of Bioinformatics in the Computational and Molecular Neuroscience Laboratory (CMN)
  • Athena Swan Departmental Lead
  • Alzheimer's Research UK Senior Fellow
  • DEMON (Deep Dementia Phenotyping Network) Biomarkers Working Group Co-Lead

Research and Interests

RESEARCH SUMMARY:

My main research focus is on using genomic and proteomic data analysis from Alzheimer’s disease, Parkinson’s disease and healthy population cohorts to develop new biomarkers and understand disease mechanisms by applying integrative and machine learning methodologies. 

I lead research on projects studying proteomics in Parkinson's disease, aiming to gain deeper insights into the disease's pathophysiology and progression. By analysing protein expression patterns, we strive to develop strategies for stratifying patients based on their unique disease characteristics and mechanisms. I am also interested in the relationship between iron homeostasis and dementia. This involves the application of large-scale multi-omics data to develop new biomarkers and understand disease mechanisms.  

BIOGRAPHY:

I am an Alzheimer’s Research UK Senior Research Fellow. I am leading the bioinformatics team working on the analysis of multiple data types including proteomic, genomics and epidemiology in patient cohorts, biobanks, experimentally derived and real-world data. I hope to use these methods to better understand disease variants and therapeutics in age-related diseases.

I have worked in the Department of Psychiatry for over ten years and am also the Athena Swan representative for the department. I am also the Internal Examiner for the Clinical and Therapeutic Neuroscience Masters. I study dementia and neurodegenerative disease in the Computational and Molecular Neuroscience Group.